Holen Sie sich die Stockscreener-App
30.45
0.81%
-0.2497
Schlusskurs vom Vortag:
$30.70
Offen:
$30.63
24-Stunden-Volumen:
3,525
Relative Volume:
0.48
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-0.41%
1M Leistung:
+8.73%
6M Leistung:
+2.47%
1J Leistung:
-11.23%
1-Tages-Spanne:
$30.45
$30.74
1-Wochen-Bereich:
$30.28
$30.77
52-Wochen-Spanne:
$25.32
$35.53
Tema Heart Health Etf Stock (HRTS) Company Profile
Firmenname
Tema Heart Health Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie HRTS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HRTS
Tema Heart Health Etf
|
30.45 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
324.31 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
657.41 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
660.72 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
255.41 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
586.66 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Heart Health Etf Aktie (HRTS) Neueste Nachrichten
Tema Launches International Durable Quality ETF (ITOL) - Yahoo Finance
Medtronic Plummets 4.2% on Earnings Optimism Overshadowed by Activist Investor Moves - AInvest
The stock price of Novo-Nordisk A/S plummeted by nearly 22%; what happened? - 富途牛牛
Short Interest in Tema Heart & Health ETF (NASDAQ:HRTS) Decreases By 62.5% - Defense World
OFS Credit Company, Inc. (NASDAQ:OCCIN) Sees Significant Decline in Short Interest - Defense World
Northern Graphite (CVE:NGC) Shares Up 42.1% – Time to Buy? - Defense World
Tema Announces Liquidation of Two ETFs - Yahoo Finance
5 Small-cap Biotech ETFs to Watch - Investing News Network
How to Invest in GLP-1 Stocks - The Motley Fool
AMGEN AND FOOTBALL LEGEND BARRY SANDERS HIGHLIGHT DANGERS OF BAD CHOLESTEROL IN NEW DOCUMENTARY - Investing News Network
Weight-Loss Drug ETFs Generate Skinnier Returns Than Expected - The Daily Upside
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177 - Investing News Network
Short Interest in Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Declines By 28.6% - Defense World
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs - ETF Trends
Why the Rich World Is Going to Need AI and Africa - Bloomberg.com
Disruptive Theme of the Week: 2024's Top Investment Themes & Trends - ETF Trends
Tema's New VOLT ETF Sparked by AI Revolution - Yahoo Finance
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win - Nasdaq
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Nasdaq
Tap the Weight-Loss Drug Market With These ETFs - Nasdaq
Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says - CNBC
Disruptive Theme of the Week: The Rise of Active Thematic ETFs - ETF Trends
HRTS: Exposure To GLP-1 Drug Developers Means Plenty Of Upside - Seeking Alpha
ETF Innovators: 11 people disrupting the industry, creating unique products, and delivering mammoth returns - Business Insider
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO - markets.businessinsider.com
This ETF is trying to satisfy appetites for weight loss stocks - CNBC
ETF IQ: Mutual Fund Managers Have the Luxury to Just Say ‘No’ - Bloomberg
Investing in the diabesity epidemic: a breakthrough moment | Opto - CMC Markets
Obesity Market to Reach $150B as Demand Grows, Supply Stabilizes: Reuters - BioSpace
Weight-loss drug forecasts jump to $150 billion as supply grows - Reuters
Play These New ETFs to Tap Lucrative Weight Loss Drug Market - Yahoo Finance
Fighting Obesity Using ETFs - ETF Trends
S&P 500: April Selloff Could Be a Very Good Thing for the Months Ahead - Investing.com India
IBD Stock Of The Day Pops After Obesity Drug Crushes Sales Views - Investor's Business Daily
What Is a Healthcare ETF? Everything You Need to Know - ETF.com
The 5 Best Biotech ETFs of 2024 - ETF.com
This weight-loss ETF has performed well. Here’s a look at other options. - MarketWatch
First Weight Loss ETF from Tema ETFs Announces Name Change, Tops $50 Million AUM - Markets Insider
Feisty Rivals Take On Eli Lilly, Novo Nordisk On Weight Loss - Investor's Business Daily
Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering - Value The Markets
Tema Launches Third Medical-Themed ETF - FA Mag
The Truth HRTS - TheStreet
LLY Stock: Study Highlights Weight Regain Risk with Lilly's Zepbound - Value The Markets
New ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of trade - MarketWatch
A new ETF will allow investors to cash in on the Ozempic-fueled weight loss craze that's swept markets this year - markets.businessinsider.com
Inside Tema ETFs' New Oncology ETF (CANC) - Yahoo Finance
Tema’s Maurits Pot Talks New Luxury and Reshoring ETFs and the Active Approach - Yahoo Finance
Finanzdaten der Tema Heart Health Etf-Aktie (HRTS)
Es liegen keine Finanzdaten für Tema Heart Health Etf (HRTS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.61%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):